Biotech Startup Biotech Biotech says that male offspring is effective for at least two years.

Today, almost all the options for identifying the available birth control are female contraceptives. However, Contraline Biotechnine claims that clinical trials of non -hormonal and reflected male pregnancys have reached a critical landmark.

in press release Today, Contraline announced that male contraceptives, called Adam, proved that it was effective and safe for 24 months in the first clinical experience of man. While its clinical results have not yet been published in a scientific journal, the company plans to issue additional data during the American Urban Paths Association (AUA) meeting on April 26.

Adam is a water-soluble hydrogel that is injected into the VASA-Anbin Index in men with sperm from the testes to the urine-a simple procedure. Sperm planting prevents sperm while still allows ejaculation to steal, and Contraline was marketing as a future, long -term, reflected, convenient condom and cells.

“Our goal was to create a male contraceptive option for two years, responding directly to the needs of consumers,” said Alexander Pistosk, chief medical official at Contraline. “These results confirm that Adam, our new water -soluble hydrogen, can achieve the intended age. We are still optimistic about his safety, effectiveness, and opposite, and his ability to give men and husbands greater reproductive control.”

This teacher relies on participants in the first human clinical experience that shows AzoSpermia (no sperm in ejaculation) in 24 months. in A former press releaseContraline claimed that Adam caused a decrease of 99.8 % to 100.0 % in the number of moving sperm within 30 days of planting.

“We took one step from converting the coordinated scene.” They suggest that “it is possible to achieve similar levels of effectiveness such as long -acting contraceptives such as IUDS. Ultimately, I would like to make Adam become” not thinking “for men when it comes to looking at their contraceptive options.” Iuds, or Insoir devicesThey are the small female contraceptives that were inserted into the womb.

According to the last news statement, none of the participants mentioned Dangerous negative eventsOr face the inexpensive safety concerns. Researchers who are conducting clinical experience will continue to monitor other participants in the 12, 15, 18 and 21 months of the laboratory and sperm test at home. Moreover, Contraline has received full organizational approval to start the second stage of the study.

However, John Awatley, a professor at the Faculty of Biological Molecular Sciences at Washington University, indicated that there is no general data yet confirming that Adam’s transplant is contrary to the opposite, and researchers still do not know the long -term effects of Davrnetia ban, he said, Guardian. Oltly also suggested that most men prefer a pill or a surgery correction.

but, Data from 2017 to 2019 He explains that 10.4 % of women between the ages of 15 and 49 use reflected contraceptives, such as IUD or other contraceptives that require procedures. This is less than four points behind 14 % birth control pills. If Adam really proves that he is safe and effective, then a large number of men may also choose a long -term effectiveness for injection instead of the short term to prevent other pregnancy.